- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Placebo for Bococizumab (PF-04950615;RN316)
Total 49 results
-
PfizerCompletedHyperlipidemiaUnited States, Canada
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerCompletedHyperlipidemiaKorea, Republic of, United States, Australia, Germany, Poland, Canada, Italy, Hong Kong, Czech Republic
-
PfizerTerminatedCardiovascular DiseaseFinland, United States, Netherlands, Spain, Korea, Republic of, China, Israel, Belgium, Germany, Australia, Czechia, Taiwan, Denmark, United Kingdom, Hungary, Poland, France, Mexico, Turkey, Canada, New Zealand, Colombia, Switzerland, Irelan... and more
-
PfizerCompletedHyperlipidemiaFinland, Netherlands, United States, Canada, Sweden, Korea, Republic of, Singapore, Czechia, Poland, United Kingdom, Puerto Rico, Norway
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerTerminatedCardiovascular DiseaseUnited States, Finland, Netherlands, Spain, Belgium, Germany, Czechia, Switzerland, Denmark, Australia, United Kingdom, Korea, Republic of, Hungary, Israel, Poland, Taiwan, Mexico, Turkey, Ireland, Canada, New Zealand, South Africa, Brazi... and more
-
PfizerCompletedHyperlipidemiaUnited States, Spain, Taiwan, United Kingdom, Canada, Mexico, France, Hungary, Lithuania, Colombia, Romania, Russian Federation
-
PfizerCompletedHeterozygous Familial HypercholesterolemiaCanada, Netherlands, United Kingdom, United States, Spain, Poland, Finland, Norway, South Africa, Italy, Bulgaria
-
PfizerCompletedHypercholesterolemiaJapan
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
PfizerCompletedMetabolic Diseases | Dyslipidemias | Lipid Metabolism Disorders | Hypercholesterolemia | HyperlipidemiasUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States
-
PfizerCompletedDyslipidemia | HypercholesterolemiaUnited States, Canada
-
University of California, San FranciscoPfizer; San Francisco General HospitalTerminatedCardiovascular Disease | DyslipidemiaUnited States
-
PfizerCompletedHypercholesterolemiaUnited States
-
PfizerWithdrawnPrimary Hyperlipidemia or Mixed DyslipidemiaChina
-
PfizerRecruitingPulmonary Arterial HypertensionUnited States
-
PfizerCompletedHealthy | Chronic Rhinosinusitis With Nasal Polyps | Atopic DermatitisUnited States
-
PfizerCompletedChronic Obstructive Pulmonary Disease (COPD)United Kingdom
-
PfizerCompletedAnorexia | Breast Cancer | Fatigue | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Cachexia | Non-small Cell Lung Cancer | Loss of AppetiteUnited States, Canada
-
PfizerCompleted
-
PfizerTerminated
-
PfizerCompletedPsoriasisCanada, United States, Japan, Poland
-
PfizerCompleted
-
PfizerCompleted
-
PfizerTerminated
-
PfizerCompleted
-
PfizerCompletedDiabetes Mellitus, Type 2United States
-
PfizerNot yet recruiting
-
PfizerTerminatedDiabetes Mellitus, Type 2United States
-
PfizerCompleted
-
PfizerCompletedHealthy VolunteersUnited States
-
PfizerCompletedUlcerative ColitisUnited States, Spain, Israel, Korea, Republic of, Russian Federation, Turkey, Czechia, Hungary, Italy, Poland, Bulgaria, Denmark, Germany, Serbia, Austria, Slovakia, Ukraine, Georgia, Romania
-
PfizerCompleted
-
PfizerCompletedRheumatoid ArthritisUnited States, Spain, Czechia, Serbia, Singapore, Taiwan, Hungary, Ukraine, Hong Kong, Korea, Republic of, Russian Federation, Slovakia, Turkey
-
PfizerCompleted
-
PfizerTerminatedHealthy VolunteersUnited States
-
PfizerCompletedCOVID-19United States, Russian Federation, Thailand, Czechia, Colombia, Bulgaria, Japan, South Africa, Turkey, Argentina, Hungary, Malaysia, Mexico, Poland, Spain, Ukraine, Brazil
-
PfizerCompleted
-
PfizerCompletedDiabetic Neuropathy, PainfulUnited States
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Deltanoid PharmaceuticalsCompletedKidney Failure, Chronic | Hyperparathyroidism, SecondaryUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 RearrangementsUnited States